UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004200
Receipt number R000002440
Scientific Title Pharmacological intervention of Atorvastatin vs. Rosvastatin in patients with Acute coronary Syndrome (ATRAS study)
Date of disclosure of the study information 2010/09/13
Last modified on 2016/10/24 18:49:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pharmacological intervention of Atorvastatin vs. Rosvastatin in patients with Acute coronary Syndrome (ATRAS study)

Acronym

ATRAS study

Scientific Title

Pharmacological intervention of Atorvastatin vs. Rosvastatin in patients with Acute coronary Syndrome (ATRAS study)

Scientific Title:Acronym

ATRAS study

Region

Japan


Condition

Condition

Coronary Artery Disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To prospective evaluate of atorvastatin and rosvastatin efficacy in patients with coronary artery disease after coronary intervention.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase IV


Assessment

Primary outcomes

1:plaque evaluation using IVUS
2:EPC function, immunological response of monocyto
3:all cause death, all cause cardiovascular event
4:repeat revascularization

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Atorvastatin (10mg/day).
Study preriod is Dec. 2008-Sep. 2010.

Interventions/Control_2

Rosvastatin (2.5mg/day)
Study preriod is Dec. 2008-Sep. 2010.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Inclusion Criteria
1) Coroanry artery disease with hyperlipidemia,
2) Acceptable for prescription of Atorvastatin and rosvastatin
3) ACC/AHA guideline diagnositic criteria (J Am Coll Cardiol. 2002;40:1366-74)
4) Patients after coronary intervention
5) Acceptable follow up in our center
6) Age: over 20 years old
7) Sex: undetermined

Key exclusion criteria

Exclusion Criteria
1) stand by scheduled CABG during study period
2) valvelar heart disease
3) chronic lung disease, cor plumonale
4) poor prognosis disease (malignant tumor etc.) within 5 years
5) bilateral renal artery stenosis, one-side kidney and renal artery stenosis, high potassium (K 5.0mEq/L), renal insufficiency (creatine 3.0mg/dL), liver dysfunction (AST>100 U/L, ALT>100U/L), anemia (Hb <6.0mg/dL)
6) in pregnancy (including suspicious state) , the lactation period
7) drug allergy for HMG-CoA reductase inhibitor
8) contraindication of HMG-CoA reductase inhibitor
9) could not obtained written informed consent
10) unfavorable patient for this study protocol

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomonori Itoh

Organization

Iwate Medical University

Division name

Division of Cardiology,Department of Internal Medicine, Memorial Heart Center

Zip code


Address

19-1, Uchimaru, Morioka city, Iwate 020-8505, Japan

TEL

019-651-5111

Email

tomoitoh@iwate-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomonori Itoh

Organization

Iwate Medical University

Division name

Division of cardiology, Department of Internal Medicine, Memorial Heart Center

Zip code


Address

19-1, Uchimaru, Morioka city, Iwate 020-8505, Japan

TEL

019-651-5111

Homepage URL


Email

tomoitoh@iwate-med.ac.jp


Sponsor or person

Institute

Division of cardiology, Department of Internal Medicine, Memorial Heart Center, Iwate Medical University

Institute

Department

Personal name



Funding Source

Organization

Division of cardiology, Department of Internal Medicine, Memorial Heart Center, Iwate Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岩手医科大学循環器医療センター(岩手県)


Other administrative information

Date of disclosure of the study information

2010 Year 09 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 09 Month 04 Day

Date of IRB


Anticipated trial start date

2008 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 09 Month 13 Day

Last modified on

2016 Year 10 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002440